{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:50Z","timestamp":1790270930886,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,25]]},"DOI":"10.7759\/cureus.20682","type":"journal-article","created":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T15:16:32Z","timestamp":1640445392000},"source":"Crossref","is-referenced-by-count":4,"title":["An Uncommon Incidence of Drug-Induced Immune Hemolytic Anemia Secondary to Ceftriaxone"],"prefix":"10.7759","author":[{"given":"Aishwarya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendranath","family":"Mannuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: the last 30 years of changes","volume":"30","author":"Arndt PA","year":"2014","unstructured":"Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology. 2014, 30:44-54.","journal-title":"Immunohematology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy","volume":"24","author":"Garratty G","year":"2010","unstructured":"Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010, 24:143-50. 10.1016\/j.blre.2010.06.004","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","volume":"2009","author":"Garratty G","year":"2009","unstructured":"Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009, 2009:73-9. 10.1182\/asheducation-2009.1.73","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000440673","article-title":"Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre","volume":"42","author":"Mayer B","year":"2015","unstructured":"Mayer B, Bartolmas T, Yurek S, Salama A. Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother. 2015, 42:333-9. 10.1159\/000440673","journal-title":"Transfus Med Hemother"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-102","article-title":"How we investigate drug-induced immune hemolytic anemia","volume":"30","author":"Leger RM","year":"2014","unstructured":"Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology. 2014, 30:85-94.","journal-title":"Immunohematology"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-100","article-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007","volume":"30","author":"Garratty G","year":"2014","unstructured":"Garratty G, Arndt PA. Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology. 2014, 30:66-79.","journal-title":"Immunohematology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000598","article-title":"Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature","volume":"26","author":"Seltsam A","year":"2000","unstructured":"Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000, 26:1390-4. 10.1007\/s001340000598","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20839","article-title":"Ceftriaxone induced hemolysis complicated by acute renal failure","volume":"50","author":"Kapur G","year":"2008","unstructured":"Kapur G, Valentini RP, Mattoo TK, Warrier I, Imam AA. Ceftriaxone induced hemolysis complicated by acute renal failure. Pediatr Blood Cancer. 2008, 50:139-42. 10.1002\/pbc.20839","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12140","article-title":"Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis","volume":"25","author":"Liu W","year":"2014","unstructured":"Liu W, Yu D. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis. Pediatr Allergy Immunol. 2014, 25:101-2. 10.1111\/pai.12140","journal-title":"Pediatr Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014548310","article-title":"Ceftriaxone-induced immune hemolytic anemia","volume":"48","author":"Neuman G","year":"2014","unstructured":"Neuman G, Boodhan S, Wurman I, Koren G, Bitnun A, Kirby-Allen M, Ito S. Ceftriaxone-induced immune hemolytic anemia. Ann Pharmacother. 2014, 48:1594-604. 10.1177\/1060028014548310","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79160-an-uncommon-incidence-of-drug-induced-immune-hemolytic-anemia-secondary-to-ceftriaxone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:28Z","timestamp":1707507028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79160-an-uncommon-incidence-of-drug-induced-immune-hemolytic-anemia-secondary-to-ceftriaxone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,25]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.20682","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,25]]}}}